Luen, S., Salgado, R., Dieci, M., Vingiani, A., Curigliano, G., Gould, R., . . . Lo,i S. (2019). Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy.
Citación estilo ChicagoLuen, SJ, et al. Prognostic Implications of Residual Disease Tumor-infiltrating Lymphocytes and Residual Cancer Burden in Triple-negative Breast Cancer Patients After Neoadjuvant Chemotherapy. 2019.
Cita MLALuen, SJ, et al. Prognostic Implications of Residual Disease Tumor-infiltrating Lymphocytes and Residual Cancer Burden in Triple-negative Breast Cancer Patients After Neoadjuvant Chemotherapy. 2019.
Precaución: Estas citas no son 100% exactas.
